Showing results (41-50 of 220) with videos related to
Sort By:
Pageof 22
International Journal of Immunopharmacology|January 1, 1990
Interference of the induction of suppressor cells by a streptococcal preparation, OK-432 through the blocking of suppressor inducer T-cellsT Toge, K Kuroi, N Baba, et al.Anticancer Research|November 1, 1993
Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumorsH Kawami, K Yoshida, A Ohsaki, et al.Asia-Pacific Journal of Clinical Oncology|April 4, 2017
Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patientsL W C Chow, L Biganzoli, A D Leo, et al.British Journal of Cancer|January 15, 2009
Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in JapanM Kondo, S-L Hoshi, M ToiCurrent Molecular Medicine|November 21, 2009
Anti-angiogenic cancer therapy updatesA M Ali, M Toi, T UenoBritish Journal of Cancer|December 1, 1993
cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivoM Toi, A L Harris, R BicknellBiochemical and Biophysical Research Communications|February 14, 1991
Interleukin-4 is a potent mitogen for capillary endotheliumM Toi, A L Harris, R BicknellCancer Research|January 15, 1992
Inhibition of colon and breast carcinoma cell growth by interleukin-4M Toi, R Bicknell, A L HarrisImmunological Investigations|September 1, 1996
Homology of partial primary sequences between alpha-enolase and a suppressive lymphokine from human T cellsS Watanabe, C P Quan, L R Smith, et al.Japanese Journal of Cancer Research : Gann|October 1, 1994
Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancerM Toi, S Hoshina, T Takayanagi, et al.Pageof 22